Drugs for Small Cell Cancer of the Lung (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 763)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Erlotinib |
Approved, Investigational |
Phase 4 |
|
183319-69-9, 183321-74-6 |
176870 |
Synonyms:
[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
[6,7-Bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine
11C Erlotinib
11C-Erlotinib
CP-358
CP-358,774
CP-358774
CP-35877401
CP-358774-01
ERLOTINIB
Erlotinib HCL
Erlotinib hydrochloride
Erlotinibum
|
HCL, Erlotinib
Hydrochloride, erlotinib
N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
NSC 718781
NSC 718781|OSI 744|OSI-774|R 1415|Tarceva®
OSI 744
OSI 774
OSI-774
R 1415
R-1415
RG-1415
RO-508231
Tarceva
|
|
2 |
|
Vinblastine |
Approved |
Phase 4 |
|
865-21-4 |
241903 13342 |
Synonyms:
(2a,2'b,3b,4a,5b)-VINCALEUKOBLASTINE
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(2Α,2'β,3β,4α,5β)-vincaleukoblastine
[3H]-VINBLASTINE
29060-LE|Velban®|Velbe®|vincaleucoblastin|vincaleukoblastine
Cell pharm brand OF vinblastine sulfate
Cellblastin
EG labo brand OF vinblastine sulfate
Faulding brand OF vinblastine sulfate
Gastrozepin brand OF vinblastine sulfate
Gry brand OF vinblastine sulfate
Hexal brand OF vinblastine sulfate
Lemblastine
Lemery brand OF vinblastine sulfate
Lilly brand OF vinblastine sulfate
Nincaluicolflastine
NSC-47842
Rozevin
|
Sulfate, vinblastine
Velban
Velbe
Vinblastin
Vinblastin hexal
Vinblastina
Vinblastina [Dcit]
Vinblastina lilly
Vinblastine
Vinblastine sulfate
Vinblastinsulfat-gry
Vinblastinum
Vinblastinum [INN-Latin]
Vincaleucoblastin
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
VLB
|
|
3 |
|
Sunitinib |
Approved, Investigational |
Phase 4 |
|
557795-19-4 |
5329102 |
Synonyms:
5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide
SU011248
SU-011248
SU11248
SU-11248
|
SU11248|Sutent®
SUNITINIB
Sunitinib malate
Sunitinibum
Sutent
|
|
4 |
|
Caffeine |
Approved |
Phase 4 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
5 |
|
Dabrafenib |
Approved, Investigational |
Phase 4 |
|
1195765-45-7 |
44462760 |
Synonyms:
DABRAFENIB
DRB436
GSK2118436
GSK-2118436
|
GSK2118436|GSK2118436A|Tafinlar®
GSK2118436a
GSK-2118436A
TAFINLAR
|
|
6 |
|
Ondansetron |
Approved, Withdrawn |
Phase 4 |
|
99614-02-5 |
4595 |
Synonyms:
A04AA01
Apo-ondansetron
DESMETHYLONDANSETRON
Dihydrate, ondansetron monohydrochloride
EUR-1025
GR-38032
GR-38032F
GR-38032F/GR-38032|ondansetron hydrochloride|ondansetron hydrochloride dihydrate|Zofran®
Hydrochloride, ondansetron
Monohydrochloride dihydrate, ondansetron
Monohydrochloride, ondansetron
Novo-ondansetron
ONDANSETRON
Ondansetron hydrochloride
|
Ondansetron monohydrochloride
Ondansetron monohydrochloride dihydrate
Ondansetron, (+,-)-isomer
Ondansetron, (R)-isomer
Ondansetron, (S)-isomer
PHL-ondansetron
PMS-ondansetron
Ratio-ondansetron
Sandoz ondansetron
Zofran
Zofran odt
Zophren
Zudan
ZUPLENZ
|
|
7 |
|
Morphine |
Approved, Investigational |
Phase 4 |
|
57-27-2 |
5288826 |
Synonyms:
(-)-Heroin hydrochloride
(-)-Morphine
(−)-MORPHINE
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
ANHYDROUS MORPHINE
Apokyn
Astramorph PF
AVINZA
Chloride, morphine
Contin, MS
D-(-)-Morphine
DEPODUR
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dulcontin
Duramorph
Duramorph PF
Duromorph
Epimorph
Heroin hydrochloride
Heroine hydrochloride
IDS-NM-009
INFUMORPH
KADIAN
l-Morphine
M.O.S
Meconium
M-Eslon
Morfina
Morfina dosa
|
Morphia
Morphin
Morphina
MORPHINE
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
morphine sulfate|Ms Contin®|Oramorph®
Morphinism
Morphinum
Morphitec
Morphium
Moscontin
MS Contin
MS/L
MS/S
MSIR
N02AA01
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
ORAMORPH
Oramorph SR
Ospalivina
Rescudose
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
Statex
Statex Drops
Substitol
Sulfate, morphine
|
|
8 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
9 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
10 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
11 |
|
Cisatracurium |
Approved, Investigational |
Phase 4 |
|
96946-41-7 |
62887 |
Synonyms:
(1r,2r,1'r,2'r)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R,2R,1'r,2'r)-Atracurium
(1R-cis,1'r-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R-cis,1'r-cis)-Atracurium
CISATRACURIUM
|
Cisatracurium besilate
Cisatracurium besylate
Cisatracurium cation
Cisatracurium ion
Nimbex
|
|
12 |
|
Ropivacaine |
Approved |
Phase 4 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(+-)-Ropivacaine
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-(−)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE
(S)-ROPIVACAINE
1 Propyl 2',6' pipecoloxylidide
1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
1-Propyl-2',6'-pipecoloxylidide
1-propyl-2',6'-pipecoloxylidide|AL-381|LEA-103|Naropin®|ropivacaine hydrochloride
AL-381
DL-Ropivacaine
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-N-Propylpipecolic acid-2,6-xylidide
Naropeine
|
Naropin
N-N-Propylpipecolate-2,6-xylidide
N-N-Propylpipecolic acid-2,6-xylidide
Racemic ropivacaine
rac-Ropivacaine
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
|
|
13 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
14 |
|
Magnesium sulfate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
7487-88-9 |
|
Synonyms:
Magnesium sulfate (1:1)
Magnesium sulfate anhydrous
Magnesium sulphate
|
magnesium(II) sulfate
Magnesiumsulfat
MgSO4
|
|
15 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
16 |
|
Tramadol |
Approved, Investigational |
Phase 4 |
|
27203-92-5 |
33741 5523 |
Synonyms:
(+)-Tramadol
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol
(1RS,2RS)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)-CYCLO-HEXANOL
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol|Maxitram®|Tilodol®|Tramacet®
1a Brand OF tramadol hydrochloride
AbZ brand OF tramadol hydrochloride
Acis brand OF tramadol hydrochloride
Adolonta
Aliud brand OF tramadol hydrochloride
Allphar brand OF tramadol hydrochloride
Alpharma brand OF tramadol hydrochloride
Amadol
Amanda
Antigen brand OF tramadol hydrochloride
ASTA medica brand OF tramadol hydrochloride
Azupharma brand OF tramadol hydrochloride
Basics brand OF tramadol hydrochloride
Bayvit brand OF tramadol hydrochloride
Betapharm brand OF tramadol hydrochloride
Bexal brand OF tramadol hydrochloride
Biocodex brand OF tramadol hydrochloride
Biodalgic
Biokanol
Byk brand OF tramadol hydrochloride
Christiaens brand OF tramadol hydrochloride
Ciclum brand OF tramadol hydrochloride
Cinfa brand OF tramadol hydrochloride
Clonmel brand OF tramadol hydrochloride
Contramal
Crispin
CSL Brand OF tramadol hydrochloride
Docpharm brand OF tramadol hydrochloride
Dolorgiet brand OF tramadol hydrochloride
Edigen brand OF tramadol hydrochloride
Elerte brand OF tramadol hydrochloride
Erempharma brand OF tramadol hydrochloride
ETS6103
ETS-6103
Expanscience brand OF tramadol hydrochloride
Grunenthal brand OF tramadol hydrochloride
Hameln brand OF tramadol hydrochloride
Heumann brand OF tramadol hydrochloride
Hexal brand OF tramadol hydrochloride
Janssen brand OF tramadol hydrochloride
Juta brand OF tramadol hydrochloride
Jutadol
Kade brand OF tramadol hydrochloride
Kern brand OF tramadol hydrochloride
Knoll brand OF tramadol hydrochloride
Krewel brand OF tramadol hydrochloride
Lakeside brand OF tramadol hydrochloride
Lichtenstein brand OF tramadol hydrochloride
Lindopharm brand OF tramadol hydrochloride
Mabo brand OF tramadol hydrochloride
MAXITRAM
Medix brand OF tramadol hydrochloride
Merck dura brand OF tramadol hydrochloride
MTW Brand OF tramadol hydrochloride
MTW Tramadol
MTWTramadol
MTW-Tramadol
Mundipharma brand OF tramadol hydrochloride
Nobligan
Normon brand OF tramadol hydrochloride
Ortho brand OF tramadol hydrochloride
Prontofort
Q Pharm brand OF tramadol hydrochloride
Q-Pharm brand OF tramadol hydrochloride
Ralivia ER
Ralivia Flashtab
Ranitidin 1a pharma
Ratiopharm brand OF tramadol hydrochloride
Rowa brand OF tramadol hydrochloride
Searle brand OF tramadol hydrochloride
Stadapharm brand OF tramadol hydrochloride
TAD brand OF tramadol hydrochloride
|
Takadol
Theradol
Theraplix brand OF tramadol hydrochloride
TILODOL
Tiral
Topalgic
Tradol
Tradol puren
Tradol-puren
TradolPuren
Tradonal
Tralgiol
Trama 1a pharma
Trama abz
Trama dorsch
Trama KD
Tramabeta
TRAMACET
Tramadin
Tramadoc
Tramadol
Tramadol 1a
Tramadol acis
Tramadol al
Tramadol asta medica
Tramadol basics
Tramadol bayvit
Tramadol bexal
Tramadol cinfa
Tramadol dolgit
Tramadol edigen
Tramadol hameln
Tramadol HCl
Tramadol HCl BP/EP
Tramadol heumann
Tramadol hydrochloride
Tramadol kern
Tramadol lichtenstein
Tramadol lindo
Tramadol mabo
Tramadol normon
Tramadol PB
Tramadol ratiopharm
Tramadol stada
Tramadol viatris brand
Tramadol-dolgit
TramadolDolgit
Tramadol-hameln
TramadolHameln
Tramadolor
Tramadolratiopharm
Tramadol-ratiopharm
Tramadolum
Tramadolum [INN-Latin]
Trama-dorsch
TramaDorsch
Tramadura
Tramagetic
Tramagit
Tramake
Tramal
Tramex
Tramodol Hcl
Tramundin
Trasedal
Tridural
ULTRACET
Ultram
Ultram ER
Viatris brand OF tramadol
Xymel 50
Zambon brand OF tramadol hydrochloride
Zamudol
Zumalgic
Zydol
Zytram
|
|
17 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1, 1867-66-9 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
Calipsol
Calypsol
CI 581 base
CLSTA 20
DL-Ketamine
Esketamine
Kalipsol
Ketaject
Ketalar
|
Ketalar base
Ketalar|ketamine HCl
Ketamina
KETAMINE
Kétamine
Ketamine base
Ketamine HCL
Ketamine hydrochloride
Ketaminum
Ketanest
Ketaset
Ketolar
L-Ketamine
NMDA
NSC-70151
Special K
Tekam
|
|
18 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-PREGABALIN
(S+)-3-isobutyl gaba
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-Isobutyl gaba
ALZAIN
AXALID
CI 1008
CI-1008
|
GABA, 3-isobutyl
LECAENT
Lyrica
LYRICA CR
NERVALIN
PD 144723
PD-144723
PREGABALIN
Pregabalina
REWISCA
S-(+)-3-ISOBUTYLGABA
YNP-1807
|
|
19 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
20 |
|
Desflurane |
Approved |
Phase 4 |
|
57041-67-5 |
42113 |
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
(±)-2-difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane
1,2,2,2-Tetrafluoroethyl difluoromethyl ether
Baxter anaesthesia brand OF desflurane
Baxter brand OF desflurane
DESFLURANE
DESFLURANO
Desflurano [INN-Spanish]
|
DESFLURANUM
Desfluranum [INN-Latin]
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
HFE-236EA2
I-653
Ohmeda brand OF desflurane
Suprane
Zeneca brand OF desflurane
|
|
21 |
|
Clonidine |
Approved |
Phase 4 |
|
4205-91-8, 4205-90-7 |
2803 20179 |
Synonyms:
2-((2,6-Dichlorophenyl)imino)imidazolidine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2-[(2,6-Dichlorophenyl)imino]imidazoline
Adesipress
Boehringer ingelheim brand OF clonidine hydrochloride
Catapres
CATAPRES P.L.
CATAPRES TTS 1
CATAPRES TTS 2
CATAPRES TTS 3
Catapres®|Kapvay®
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Chlofazoline
Chlophazolin
Chlornidinum
Clofelin
Clofenil
Clonidin
Clonidina
Clonidine
Clonidine dihydrochloride
CLONIDINE HCL
Clonidine hydrochloride
|
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
CLORPRES
COMBIPRES
DICHLORANILINO IMIDAZOLIN
Dihydrochloride, clonidine
Dixarit
DURACLON
Duraclont
Gemiton
Hemiton
Hydrochloride, clonidine
Ipotensium
Isoglaucon
JENLOGA
KAPVAY
KAPVAY®
Klofelin
Klofenil
Monohydrobromide, clonidine
Monohydrochloride, clonidine
ST 155BS
ST-155
ST-155BS
ST-155-BS
Tenso-Timelets
|
|
22 |
|
Droperidol |
Approved, Vet_approved |
Phase 4 |
|
548-73-2 |
3168 |
Synonyms:
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one
1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one
Dehidrobenzperidol
Dehydrobenzperidol
DRIDOL
Droleptan
Droperidol
Dropéridol
|
Droperidolo
Droperidolum
Inapsine
Janssen brand OF droperidol
Kern brand OF droperidol
MCN-JR-4749
NSC-169874
R-4749
Taylor brand OF droperidol
|
|
23 |
|
Scopolamine |
Approved, Investigational |
Phase 4 |
|
51-34-3 |
153311 3000322 |
Synonyms:
(-)-Atropine
(-)-Hyoscine
(-)-Hyoscine hydrobromide
(-)-Hyoscyamine
(-)-Scopolamine
(-)-Scopolamine bromide
(-)-Scopolamine hydrobromide
(+)-Hyoscine
(+)-Scopolamine
(±)-Atropine
(±)-Hyoscyamine
(1R,2R,4S,5S,7S)-9-METHYL-3-OXA-9-AZATRICYCLO[3.3.1.0?,?]NONAN-7-YL (2S)-3-HYDROXY-2-PHENYLPROPANOATE
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate
(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoic acid
(S)-(-)-Hyoscyamine
(S)-Atropine
1alphaH,5alphaH-Tropan-3alpha-yl (-)-tropate
1αH,5αH-Tropan-3α-yl (-)-tropate
6,7-Epoxytropine tropate
6,7-Epoxytropine tropic acid
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropate
6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropic acid
6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate
6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropic acid
6β,7β-Epoxy-3α-tropanyl S-(-)-tropate
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropate
6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropic acid
9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol (-)-tropate
a-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
a-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
alpha-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
Atrochin
Atropin
Atropine
Atropinum sulfuricum
Atropinum sulphuricum
Atroquin
Beldavrin
Buscopan
Cystospaz
Daturine
dl-Hyoscyamine
dl-Tropyl tropate
Duboisine
Epoxytropine tropate
Euscopol
|
Hydroscine hydrobromide
Hyosceine
Hyoscine
Hyoscine bromide
Hyoscine hydrobromide
hyoscine|levo-duboisine|Scopoderm®
Hyoscyamine
Hyoscyine hydrobromide
Hyosol
Hysco
Isopto hyoscine
ISOPTPO HYOSCINE
Isoscopil
Kwells
l-Atropine
LEVO-DUBOISINE
L-Hyoscine hydrobromide
L-Hyoscyamin
l-Hyoscyamine
l-Scopolamine
L-Scopolamine-hydrobromide
l-Tropine tropate
Methscopolamine bromide
Norhyoscine
Oscine
Pamine
S-(-)-Tropate
Scop
Scopamin
scopine (−)-tropate
Scopine (-)-tropate
Scopine (-)-tropic acid
Scopine tropate
SCOPODERM
SCOPOLAMINE
Scopolamine bromide
Scopolamine hydrobromide
Scopolaminium bromide
Scopolammonium bromide
SEE
Tranaxine
TRANSDERM SCOP
Transderm-scop
Tropine (±)-tropate
Tropine tropate
Α-(hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
Α-(hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester
|
|
24 |
|
Topotecan |
Approved, Investigational |
Phase 4 |
|
123948-87-8, 119413-54-6 |
60699 60700 |
Synonyms:
9 Dimethylaminomethyl 10 hydroxycamptothecin
9-[(Dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin
9-Dimethylaminomethyl-10-hydroxycamptothecin
Hycamptamine
HYCAMPTIN
Hycamtamine
Hycamtin
Hydrochloride, nogitecan
Hydrochloride, topotecan
Nogitecan hydrochloride
NSC-609699
Potactasol
SK And F 104864 a
SK And F104864a
SK And F-104864-a
|
SK&F-S-104864A
SKF-104864
SK-S-104864-A
SmithKline beecham brand OF topotecan hydrochloride
Topotecan
TOPOTECAN HCL
Topotecan hydrochloride
Topotecan lactone
Topotecan monohydrochloride, (S)-isomer
Topotecane
Topotecane [INN-French]
Topotecanum
Topotecanum [INN-Latin]
TPT
TTC
|
|
25 |
|
Methotrexate |
Approved |
Phase 4 |
|
1959-05-2, 59-05-2 |
4112 126941 |
Synonyms:
[<sup>3</sup>H]-methotrexate
2-[(4-{[(4-amino-2-imino-2,3-dihydropteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioate
4-Amino-10-methylfolate
4-Amino-10-methylfolic acid
4-Amino-N(10)-methylpteroylglutamate
4-Amino-N(10)-methylpteroylglutamic acid
ABITREXATE
Abitrexate®|amethopterin|Nordimet®|Rasuvo®
Amethopterin
Amethopterine
Antifolan
Arbitrexate
CL-14377
Dicesium salt methotrexate
EBETREX
EMT-25299
Emtexate
EMTEXATE HIGH-POT
EMTEXATE PF
Emtexic acid
FOLEX
HDMTX
Hydrate, methotrexate
L-Amethopterin
Ledertrexate
Ledertrexic acid
MAXTREX
Metatrexan
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate
Méthotrexate
Methotrexate hydrate
|
Methotrexate sodium
Methotrexate, (D)-isomer
Methotrexate, (DL)-isomer
Methotrexate, dicesium salt
Methotrexate, disodium salt
Methotrexate, sodium salt
Methotrexatum
Methotrexic acid
Methylaminopterin
Methylaminopterinum
METOJECT
Metotrexato
Mexate
MEXATE-AQ
MTX
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
N-Bismethylpteroylglutamic acid
NSC-740
Otrexup
OTREXUP PFS
R-9985
RASUVO
Rheumatrex
R-METHOTREXATE
Sodium, methotrexate
TCMDC-123832
TCMDC-125488
TCMDC-125858
TCMDC-125858TCMDC-125488TCMDC-123832Methotrexate
TCMDC-125858TCMDC-125488TCMDC-123832Methotrexic acid
Trexall
Xatmep
ZLATAL
|
|
26 |
|
Vemurafenib |
Approved |
Phase 4 |
|
918504-65-1 |
42611257 |
Synonyms:
BRAF(V600E) KINASE INHIBITOR RO5185426
N-[3-[[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]-2,4-DIFLUOROPHENYL]-1-PROPANESULFONAMIDE
PLX 4032
PLX4032
PLX-4032
PLX4032|RG7204|Zelboraf®
RG7204
|
RG-7204
RO-5185426
RO-51-85426
VEMURAFENIB
Vémurafénib
Vemurafenibum
Zelboraf
|
|
27 |
|
Gefitinib |
Approved, Investigational |
Phase 4 |
|
184475-35-2 |
123631 |
Synonyms:
4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
GEFITINIB
Gefitinibum
Iressa
Iressa®|ZD 1839|ZD1839
Irressat
|
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide
N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine
ZD 1839
ZD1839
ZD-1839
|
|
28 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
1177-87-3 |
3680 |
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetic acid
9alpha-Fluoro-16alpha-methylprednisolone acetate
DECADRON-LA
Dexamethasone 21-acetate
|
DEXAMETHASONE ACETATE
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasone acetic acid
Dexamethasoni acetas
|
|
29 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-02-2 |
3003 5743 |
Synonyms:
[<sup>3</sup>H]-dexamethasone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16Α-methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16a-methyl-9a-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
9a-Fluoro-16a-methylprednisolone
9a-Fluoro-16BETA-methylprednisolone
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-Fluoro-16alpha-methyl-prednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9Α-fluoro-16α-methylprednisolone
Adexone
Aeroseb-D
Aeroseb-dex
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
alpha -Fluoro-16-alpha -methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Bisu DS
Calonat
Corson
Corsone
Cortisumman
DALALONE
Decacort
Decacortin
Decaderm
Decadron
Decadron Tablets, Elixir
Decadron®|desametasone|fluormethylprednisolone
DECADRON-75
DECADRON-LA
Decagel
Decaject
Decaject l.a.
Decaject-l.a.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
DEX
DEXA
Dexa mamallet
DEXACEN-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexacortin
Dexa-cortisyl
DEXACORTISYL
Dexadeltone
Dexafarma
DEXAFREE
DEXAIR
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
DEXAMETHASONE
Dexaméthasone
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
DEXAMETHASONE METASULFOBENZOATE SODIUM
DEXAMETHASONE PALMITATE
Dexamethasone sodium phosphate
|
DEXAMETHASONE VALERATE
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dexinolon
Dexinoral
Dexone
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
Dexonium
Dexpak
DEXSOL
Dextelan
DEXTENZA
DEXYCU KIT
Dezone
Dinormon
DROPODEX
DXM
DXM833
DXMS
ECR brand OF dexamethasone
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Gammacorten
GPPE EAR SPY
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Tablets
HL-Dex
ICN brand OF dexamethasone
IontoDex
Isopto-dex
ISV-305
KORTICO INJECTION
Lokalison F
Loverine
Luxazone
MARTAPAN
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merz brand 1 OF dexamethasone
Merz brand 2 OF dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
Mymethasone
Naquasone (veterinary)
NEODECADRON
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC-34521
Ocu-trol
Oradexon
OTO-104
OTOMIZE
OZURDEX
Pet derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
Sandoz dexamethasone
SK-Dexamethasone
SOFRADEX
SPERSADEX COMP
Spoloven
Sunia sol D
Superprednol
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
Visumetazone
|
|
30 |
|
Sufentanil |
Approved, Investigational |
Phase 4 |
|
56030-54-7 |
41693 |
Synonyms:
Chronogesic
Citrate, sufentanil
Curasan brand OF sufentanil citrate
Curasan, sufentanil
Hameln brand OF sufentanil citrate
IDS-NS-001
Janssen brand OF sufentanil citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
R-30730
Ratiopharm brand OF sufentanil citrate
Sufenta
Sufenta®|sufentanil citrate|Zalviso®
Sufentanil
Sufentanil citrate
|
Sufentanil curasan
Sufentanil hameln
Sufentanil ratiopharm
Sufentanil-hameln
SufentanilHameln
Sufentanilo
Sufentanil-ratiopharm
SufentanilRatiopharm
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanil Citrate
Sulfentanyl
Taylor brand OF sufentanil citrate
|
|
31 |
|
Flurbiprofen |
Approved, Investigational |
Phase 4 |
|
5104-49-4 |
3394 |
Synonyms:
(+-)-2-Fluoro-alpha-methyl-4-biphenylacetate
(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid
(+-)-2-Fluoro-a-methyl-4-biphenylacetate
(+-)-2-Fluoro-a-methyl-4-biphenylacetic acid
(+-)-2-Fluoro-α-methyl-4-biphenylacetate
(+-)-2-Fluoro-α-methyl-4-biphenylacetic acid
(±)-2-fluoro-α-methyl-4-biphenylacetic acid
2-(2-Fluorobiphenyl-4-yl)propanoate
2-(2-Fluorobiphenyl-4-yl)propanoic acid
2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetate
2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid
2-Fluoro-a-methyl-(1,1'-biphenyl)-4-acetate
2-Fluoro-a-methyl-(1,1'-biphenyl)-4-acetic acid
2-Fluoro-α-methyl-(1,1'-biphenyl)-4-acetate
2-Fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid
3-Fluoro-4-phenylhydratropate
3-Fluoro-4-phenylhydratropic acid
Abbott brand OF flurbiprofen
Adfeed
Allergan brand OF flurbiprofen sodium
Ansaid
Ansaid®|Froben®
Antadys
apo Flurbiprofen
apo-Flurbiprofen
Apotex brand OF flurbiprofen
BTS 18322
BTS-18322
Cantabria brand OF flurbiprofen
Cebutid
Crookes brand OF flurbiprofen
Dobrofen
FLP
Flubiprofen
Flugalin
FLURBIPROFEN
Flurbiprofen Axetil
Flurbiprofen pfizer brand
|
Flurbiprofen sodium
FLURBIPROFENE
Flurbiprofene [INN-French]
FLURBIPROFENO
Flurbiprofeno [INN-Spanish]
FLURBIPROFENUM
Flurbiprofenum [INN-Latin]
Fluriproben
Flurofen
Froben
Froben SR
Klosterfrau brand OF flurbiprofen
Knoll brand OF flurbiprofen
neo Artrol
novo Flurprofen
novo-Flurprofen
Novopharm brand OF flurbiprofen
Nu flurbiprofen
Nu pharm brand OF flurbiprofen
Nu-flurbiprofen
Nu-pharm brand OF flurbiprofen
Ocufen
Ocuflur
Pfizer brand OF flurbiprofen
Pharm allergan brand OF flurbiprofen sodium
Pharm-allergan brand OF flurbiprofen sodium
ratio Flurbiprofen
ratio-Flurbiprofen
Ratiopharm brand OF flurbiprofen
Recordati brand OF flurbiprofen
S-FLURBIPROFEN
Shire brand OF flurbiprofen
Sodium, flurbiprofen
Stayban
Strefen
TRANSACT
U-27182
Zepolas
|
|
32 |
|
Aspartic acid |
Approved, Nutraceutical |
Phase 4 |
|
56-84-8 |
5960 |
Synonyms:
(+)-Aspartate
(+)-Aspartic acid
(+-)-Aspartic acid
(2S)-2-AMINOBUTANEDIOIC ACID
(2S)-2-AMINOSUCCINIC ACID
(2S)-Aspartate
(2S)-Aspartic acid
(L)-Aspartate
(L)-Aspartic acid
(R)-2-Aminosuccinate
(R,S)-Aspartic acid
(S)-(+)-Aspartate
(S)-(+)-Aspartic acid
(S)-2-Aminobutanedioate
(S)-2-Aminobutanedioic acid
(S)-2-Aminosuccinate
(S)-2-Aminosuccinic acid
(S)-Aminobutanedioate
(S)-Amino-butanedioate
(S)-Aminobutanedioic acid
(S)-Amino-butanedioic acid
(S)-Aspartate
(S)-Aspartic acid
[<sup>3</sup>H]-L-aspartate|[<sup>3</sup>H]-L-aspartic acid
2-Amino-3-methylsuccinate
2-Amino-3-methylsuccinic acid
2-Aminosuccinate
2-Aminosuccinic acid
ácido aspártico
Acidum asparticum
alpha-Aminosuccinate
alpha-Aminosuccinic acid
Aminosuccinate
Ammonium aspartate
Asp
Asparagate
Asparagic acid
Asparaginate
Asparaginic acid
Asparatate
ASPARTate
Aspartate magnesium hydrochloride
Aspartate, ammonium
Aspartate, calcium
Aspartate, dipotassium
Aspartate, disodium
Aspartate, magnesium
Aspartate, monopotassium
Aspartate, monosodium
Aspartate, potassium
Aspartate, sodium
|
ASPARTIC ACID
Aspartic acid, ammonium salt
Aspartic acid, calcium salt
Aspartic acid, dipotassium salt
Aspartic acid, disodium salt
Aspartic acid, hydrobromide
Aspartic acid, hydrochloride
Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate
Aspartic acid, magnesium (2:1) salt
Aspartic acid, magnesium-potassium (2:1:2) salt
Aspartic acid, monopotassium salt
Aspartic acid, monosodium salt
Aspartic acid, potassium salt
Aspartic acid, sodium salt
Calcium aspartate
D
Dipotassium aspartate
Disodium aspartate
FEMA NO. 3656
H-Asp-OH
Hydrobromide aspartic acid
Hydrochloride aspartic acid
Hydrochloride, aspartate magnesium
L Aspartate
L Aspartic acid
L-(+)-Aspartate
L-(+)-Aspartic acid
L-Aminosuccinate
L-Aminosuccinic acid
L-Asp
L-Asp|L-aspartate
L-Asparagate
L-Asparagic acid
L-Asparaginate
L-Asparaginic acid
L-Asparaginsaeure
L-Asparaginsäure
L-Aspartate
L-Aspartic acid
Magnesiocard
Magnesium aspartate
MG 5 Longoral
MG5Longoral
MG-5-Longoral
Monopotassium aspartate
Monosodium aspartate
NSC-3973
Poly-DL-succinimide
Polysuccinimide
Potassium aspartate
Sodium aspartate
|
|
33 |
|
Creatine |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
57-00-1 |
586 |
Synonyms:
((Amino(imino)methyl)(methyl)amino)acetate
((Amino(imino)methyl)(methyl)amino)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(a-Methylguanido)acetate
(a-Methylguanido)acetic acid
(N-Methylcarbamimidamido)acetate
(N-Methylcarbamimidamido)acetic acid
(Α-methylguanido)acetate
(Α-methylguanido)acetic acid
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetate
alpha-Methylguanidino acetic acid
a-Methylguanidino acetate
a-Methylguanidino acetic acid
Cosmocair C 100
Creatin
Creatine
|
Creatine (8CI)
Creatine hydrate
Creatine, hydrate
Kreatin
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-methylglycine
N-(Aminoiminomethyl)-N-methyl-glycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
NSC-8752
Phosphagen
Pyrolysate
Α-methylguanidino acetate
Α-methylguanidino acetic acid
|
|
34 |
|
Rivoceranib |
Investigational |
Phase 4 |
|
811803-05-1 |
11315474 |
Synonyms:
APATINIB
apatinib (in China)|YN968D1
Apatinib mesylate
Rivoceranib
|
Rivoceranib mesylate
YN968D1
YN968D1 free base
|
|
35 |
|
Flurbiprofen axetil |
Investigational |
Phase 4 |
|
91503-79-6 |
|
Synonyms:
1-(Acetyloxy)ethyl 2-{2-fluoro-[1,1'-biphenyl]-4-yl}propanoic acid
1-Acetoxyethyl-2-(2-fluoro-4-biphenyl)propionate
1-Acetyloxyethyl 2-(3-fluoro-4-phenylphenyl)propanoic acid
Flurbiprofen axetil
|
|
|
36 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
37 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
38 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
39 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
40 |
|
Anesthetics |
|
Phase 4 |
|
|
|
41 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
42 |
|
Endostar protein |
|
Phase 4 |
|
|
|
43 |
|
Central Nervous System Stimulants |
|
Phase 4 |
|
|
|
44 |
|
N-Methylaspartate |
|
Phase 4 |
|
|
|
45 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
46 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
47 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
48 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
49 |
|
Diphosphonates |
|
Phase 4 |
|
|
|
50 |
|
bilirubin |
|
Phase 4 |
|
635-65-4 |
5280352 |
Synonyms:
(4Z,15Z)-Bilirubin ixa
(Z,Z)-Bilirubin ixa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoate
2,7,13,17-Tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
|
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
8,12-Bis(2-carboxyethyl)-2,7,13,17-tetramethyl-3,18-divinylbiladiene-ac-1,19(21H,24H)-dione
BILIRUBIN
Bilirubin IX alpha
Bilirubin ixalpha
Bilirubin IX-alpha
Bilirubin(Z,Z)
Bilirubin-ixalpha
Cholerythrin
Hematoidin
NSC-26685
|
|
Interventional clinical trials:
(show top 50)
(show all 6077)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride in in Combination With EC/EP |
Unknown status |
NCT03890055 |
Phase 4 |
Anlotinib Hydrochloride |
2 |
Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer: a Multi-center, Randomized, Open Label Study |
Unknown status |
NCT02348450 |
Phase 4 |
Irinotecan;Etoposide;Cisplatin |
3 |
A Single Arm, Multi-center Study to Assess the Efficacy and Safety of Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in Non-squamous Non-small-cell Lung Cancer (NSCLC) |
Unknown status |
NCT03799601 |
Phase 4 |
Anlotinib;Docetaxel;Carboplatin |
4 |
Randomised, Controlled Study Comparing Chemotherapy Plus Intercalated EGFR-Tyrosine Kinase Inhibitors Combination Therapy With EGFR-Tyrosine Kinase Inhibitors Alone Therapy as First-line Treatment for Patients With Non-Small-Cell Lung Cancer |
Unknown status |
NCT02031601 |
Phase 4 |
Erlotinib;Gefitinib;Icotinib;Docetaxel;Pemetrexed;Platinum (cisplatin or carboplatin) |
5 |
A Multicenter, Randomized, Open-label, Parallel-group Study of Paclitaxel Liposome and Cisplatin Compared With Gemcitabine and Cisplatin as First-line Therapy in Advanced Squamous Non-Small-Cell Lung Cancer |
Unknown status |
NCT02996214 |
Phase 4 |
Paclitaxel Liposome;Gemcitabine;Cisplatin |
6 |
Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen: A Prospective, Open, One-arm Clinical Study |
Unknown status |
NCT03792503 |
Phase 4 |
Apatinib;Pemetrexed |
7 |
A Phase â…£,Open,Multicenter,Single Arm Study to Evaluate the Efficacy of the Combination Conmana With Thalidomide in Patients With NSCLC(Non-Small-Cell-Lung-Cancer) |
Unknown status |
NCT02778893 |
Phase 4 |
Conmana;Thalidomide |
8 |
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer: A Non-inferiority, Randomized, Open, Parallel and Controlled Prospective Clinical Study |
Unknown status |
NCT02480634 |
Phase 4 |
Zoledronic acid |
9 |
Evaluation of the Efficacy of Domestic Gefitinib Tablets in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients Using a Multicenter, Randomized, Positive Drug Gefitinib Pharmacodynamics and Pharmacodynamics |
Unknown status |
NCT03264794 |
Phase 4 |
Gefitinib Tab (CTTQ),First medication;Gefitinib Tab (CTTQ),From the 8th day of trial;Gefitinib tablets (Yi Ruisha),First medication;Gefitinib Tab 250 MG(CTTQ),From the 8th day of trial. |
10 |
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research |
Unknown status |
NCT02513355 |
Phase 4 |
Changchun marina;cisplatin;Taxol;parapl |
11 |
A Study of Endostar in Combination With Chemotherapy Followed by Endostar Maintenance Therapy in Patients With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) |
Unknown status |
NCT01028729 |
Phase 4 |
Endostar;Gemcitabine-Cisplatin chemotherapy |
12 |
High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation (INCREASE): a Randomized, Open-label Study |
Unknown status |
NCT02404675 |
Phase 4 |
icotinib |
13 |
The Exploratory Clinical Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin (Endostar) for Local Advanced Non-small Cell Lung Cancer (NSCLC (â…¢ A / â…¢ B) ) |
Unknown status |
NCT01211002 |
Phase 4 |
radiotherapy / EP combined with recombinant human endostatin |
14 |
A Randomized,Double-blind,Placebo-Controlled,Multicenter Clinical Trail of Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer |
Unknown status |
NCT02195453 |
Phase 4 |
Yangzhengxiaoji Capsule;Placebo Capsule |
15 |
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Untreated Advanced Non-small-cell Lung Cancer: a Randomized, Open-label Study |
Unknown status |
NCT02194556 |
Phase 4 |
Sequential and maintenance icotinib;Maintenance icotinib |
16 |
A Single Center, Open Label, Multicenter Study to Determine the Safety and Efficacy of Icotinib in Combination With Whole Brain Radiation Therapy For NSCLC Patients With Brain Metastases |
Unknown status |
NCT01926171 |
Phase 4 |
Icotinib plus WBRT |
17 |
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma: a Randomized, Open-label, Multicenter Study |
Unknown status |
NCT02103257 |
Phase 4 |
Sequential Icotinib Plus Chemotherapy;Icotinib |
18 |
An Open Lable, Single Arm, Phase IV Study of Icotinib as First-line Treatment in Elder NSCLC Patients With EGFR Mutation |
Unknown status |
NCT01646450 |
Phase 4 |
Icotinib |
19 |
Randomized, Open Label, Positive Controlled, Multicenter Trial to Evaluate Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma |
Unknown status |
NCT01665417 |
Phase 4 |
Experimental;Chemotherapy |
20 |
Maintenance Gemcitabine or Best Supportive Care for the Chinese Advanced NSCLC Patients Without Progression Disease After Given Four Cycles of the Induction Chemotherapy With Gemcitabine Plus Cisplatin |
Unknown status |
NCT01336192 |
Phase 4 |
Gemcitabine;Best supportive care |
21 |
A Phase IV, Multicenter, Non-randomized, Open-labeled Study to Evaluate the Efficacy of Gefitinib (IRESSA®) as a Second-line Therapy in NSCLC Patients |
Completed |
NCT00608868 |
Phase 4 |
Gefitinib |
22 |
Safety Study of Nivolumab for Selected Advanced Malignancies in India |
Completed |
NCT03444766 |
Phase 4 |
Nivolumab |
23 |
ONCOXIN® and Quality of Life in Cancer Patients in a Real World Setting Study |
Completed |
NCT03550482 |
Phase 4 |
|
24 |
Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer |
Completed |
NCT00451906 |
Phase 4 |
Platinum-based chemotherapy;Bevacizumab [Avastin] |
25 |
A Placebo-Controlled, Multicentre, Randomised, Parallel Group, Trial to Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (StageIIIB/IV) Non Small Cell Lung Cancer (NSCLC) Chinese Patients Who HaveNot Experienced Disease Progression or Unacceptable Toxicity During Front Line Standard Platinum-Based Chemotherapy |
Completed |
NCT00770588 |
Phase 4 |
Gefitinib;Placebo |
26 |
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis |
Completed |
NCT00762346 |
Phase 4 |
zometa |
27 |
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer |
Completed |
NCT03092986 |
Phase 4 |
Paclitaxel;Carboplatin;Cisplatin;Vinblastine Sulfate |
28 |
A Prospective, Multicenter, Phase-IV Clinical Trial to Assess Safety of Osimertinib in Indian Adult Patients With Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-positive Non-small Cell Lung Cancer (NSCLC). |
Completed |
NCT03853551 |
Phase 4 |
Osimertinib |
29 |
A Phase III/IV, Single Arm, Multicenter Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (TAIL) |
Completed |
NCT03285763 |
Phase 4 |
Atezolizumab |
30 |
A Multi-center Observational Clinical Study of Screening of Non-small-cell Lung Cancer With Bone Metastasis and Efficacy and Safety of Those Receiving Bisphosphonates |
Completed |
NCT00765687 |
Phase 4 |
bisphosphates |
31 |
Phase IV Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin in Previously Untreated, Inoperable (Stage IIIa or IIIb) Non-small-cell Lung Cancer |
Completed |
NCT00686322 |
Phase 4 |
Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy) |
32 |
Open-Label Single-Arm Phase IV Study of Pemetrexed in Taiwanese Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy |
Completed |
NCT00380718 |
Phase 4 |
pemetrexed |
33 |
A Dual-Cohort, Prospective, Observational Study of Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer Patients With and Without Bone Metastasis |
Completed |
NCT00099541 |
Phase 4 |
zoledronic acid |
34 |
An International Expanded Access Clinical Programme With ZD1839 (IRESSATM) for Patients With Advanced Non-small Cell Lung Cancer (NSCLC) China Amendment 1: A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa |
Completed |
NCT01000740 |
Phase 4 |
|
35 |
A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer |
Completed |
NCT01066884 |
Phase 4 |
erlotinib [Tarceva] |
36 |
Individualized Pemetrexed Dosing in Patients With Non-small Cell Lung Cancer or Mesothelioma Based on Renal Function to Improve Treatment Response |
Completed |
NCT03655834 |
Phase 4 |
Pemetrexed |
37 |
An Expanded Access Program of Tarceva (Erlotinib) in Patients With Advanced Stage IIIB/IV Non-Small Cell Lung Cancer |
Completed |
NCT00949910 |
Phase 4 |
Erlotinib |
38 |
Multicenter Exploratory Trial of the Safety and Efficacy of Adjuvant Docetaxel and Carboplatin in Patients With Resected Non-small Cell Lung Cancer |
Completed |
NCT00883675 |
Phase 4 |
Docetaxel-Carboplatin |
39 |
A Single Arm Phase IV Study of Afatinib in Elderly Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Whose Tumors Have Epidermal Growth Factor Receptor (EGFR) Exon 19 Deletions or Exon 21(L858R) Substitution Mutations |
Completed |
NCT02514174 |
Phase 4 |
Afatinib |
40 |
Clinical Study of Recombinant Human Endostatin Combined With NP Chemotherapy in the Treatment of Stage â…¢A Non Small Cell Lung Cancer |
Completed |
NCT02497118 |
Phase 4 |
Endostatin;Vinorelbine;Cisplatin |
41 |
Post-marketing Clinical Trial of Induction Chemotherapy of Pemetrexed Plus Carboplatin Followed by Pemetrexed Maintenance Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer |
Completed |
NCT01020786 |
Phase 4 |
Pemetrexed;Carboplatin |
42 |
A Multi-centre, Open-label, Phase IV, Interventional Study to Evaluate the Efficacy of Erlotinib (Tarceva®) Following 4 Cycles of Platinum-based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Experienced Disease Progression or Unacceptable Toxicity During Chemotherapy |
Completed |
NCT01230710 |
Phase 4 |
Erlotinib |
43 |
A Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemo-naive, Advanced, Non-Small-Cell Lung Cancer Patients Aged 70 Years or Older in Taiwan |
Completed |
NCT01196078 |
Phase 4 |
erlotinib [Tarceva];vinorelbine |
44 |
SINGLE-ARM STUDY TO EVALUATE THE SAFETY OF LORLATINIB IN ALK INHIBITOR-TREATED UNRESECTABLE ADVANCED AND/OR RECURRENT ALK-POSITIVE NON-SMALL CELL LUNG CANCER PARTICIPANTS IN INDIA |
Completed |
NCT04541706 |
Phase 4 |
Lorlatinib |
45 |
A Study of Erlotinib (Tarceva®) Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor |
Completed |
NCT01287754 |
Phase 4 |
erlotinib [Tarceva] |
46 |
A Phase 3b/4 Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer |
Completed |
NCT02869789 |
Phase 4 |
Nivolumab in combination with Ipilimumab |
47 |
An Open Label, Multicentre, Single Arm Study to Characterise the Efficacy, Safety and Tolerability of Gefitinib 250 mg (IRESSAâ„¢) as First Line Treatment in Caucasian Patients, Who Have Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
Completed |
NCT01203917 |
Phase 4 |
Gefitinib |
48 |
Safety and Efficacy of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study (Abound.70+) |
Completed |
NCT02151149 |
Phase 4 |
nab-paclitaxel;Carboplatin |
49 |
An Open Label, Single-arm Phase IV Study to Assess the Efficacy and Safety of Afatinib as Second-line Therapy for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harbouring an EGFR Mutation (Del19 or L858R) Who Have Failed First-line Treatment With Platinum-based Chemotherapy |
Completed |
NCT02208843 |
Phase 4 |
Afatinib |
50 |
Phase IV Randomized Trial of Pemetrexed Followed by Docetaxel or in Reverse Sequence in Non-small-cell Lung Cancer Patients Failed Previous Chemotherapy |
Completed |
NCT01442909 |
Phase 4 |
Docetaxel and pemetrexed |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Cisplatin
CISPLATIN PWDR
Teniposide
|
Topotecan
Topotecan Hydrochloride
|
|